深康佳A(000016.SZ)一季度业绩扭亏 预盈5800万元-7400万元
格隆汇4月14日丨深康佳A(000016.SZ)披露2021年第一季度业绩预告,公司预计2021年1-3月实现归属于上市公司股东的净利润5800万元-7400万元,上年同期为亏损2.21亿元,同比实现扭亏为盈。业绩扭亏原因系:
(一)随着国内新冠疫情得到有效控制,行业景气度回升,相关业务逐步恢复正常水平,公司2021年第一季度营业收入较上年同期增长约25%;公司继续加大研发投入与科技创新力度,大力实施精品工程,提质增效,盈利能力有所提升。
(二)预计公司2021年第一季度非经常性损益对归属于上市公司股东的净利润的影响金额为4-5亿元,主要为政府补贴收入和转让所持公司股权产生的收益。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.